Breaking News Instant updates and real-time market news.

MAT

Mattel

$11.78

0.975 (9.03%)

, HAS

Hasbro

$106.65

0.95 (0.90%)

10:13
06/12/19
06/12
10:13
06/12/19
10:13

Unclear if reported MGA bid is premium for Mattel, says Jefferies

The "loose" offer for Mattel by MGA Entertainment, according to press reports, was creatively constructed to bind the two entities using MGA's estimated $400M-plus in EBITDA with forgiveness of a multi-hundred million dollar lawsuit between the companies as equity, Jefferies analyst Stephanie Wissink told investors earlier in a research note. It is not clear that the implied post-deal value is a premium to current Mattel shareholders, added the analyst, who admits she's "largely indifferent" to the stock at $11. The analyst keeps a Hold rating on the name. Mattel (MAT) in morning trading is up 8% to $11.63. Its peer Hasbro (HAS) is up 61c to $106.29.

MAT

Mattel

$11.78

0.975 (9.03%)

HAS

Hasbro

$106.65

0.95 (0.90%)

  • 12

    Jun

MAT Mattel
$11.78

0.975 (9.03%)

06/12/19
RHCO
06/12/19
NO CHANGE
RHCO
Hold
MGA Entertainment bid for Mattel faces 'uphill battle', says SunTrust
SunTrust analyst Michael Swartz kept his Hold rating on Mattel after last night's LA Times report that the company rejected a merger proposal from MGA Entertainment for the 2nd time this year and 3rd time since 2015. The analyst notes that the takeover was predicated on MGA Entertainment CEO Isaac Larian likely taking over as CEO, which would result in the removal of Mattel's entire board. Swarts further contends that consummation of the deal would be an "uphill battle" even in the presence of "material synergies" between the companies given the regulatory challenges and financial leverage assumption, since Mattel's current debt load stands at over $2.8B.
02/26/19
BMOC
02/26/19
NO CHANGE
Target $20
BMOC
Outperform
Mattel price target lowered to $20 from $23 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Mattel to $20 after attending the company's Toy Fair analyst event. The analyst states that while he is "encouraged" by its efforts to reposition business toward profitable growth, the turnaround involving "SKU rationalization,process improvement, cost reduction, and infrastructure investments" could take longer than he anticipated. Longer term, Johnson keeps his Outperform rating on Mattel and believes that the stock still has "value that will continue to be unlocked" amid the management's transformation efforts.
02/08/19
MKMP
02/08/19
NO CHANGE
Target $15
MKMP
Neutral
Mattel price target raised to $15 from $12 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Mattel to $15 after its Q4 results surprised to the upside. The analyst also keeps his Neutral rating, noting that while the cost cuts have contributed to the earnings beat, the "revenue turnaround is still a work in progress".
12/24/18
BMOC
12/24/18
NO CHANGE
Target $20
BMOC
Spin Master licensing deal with Warner negative for Mattel, says BMO Capital
BMO Capital analyst Gerrick Johnson says the Friday report of a DC superheroes licensing deal between Toys R Us Spin Master and Warner is a negative for Mattel. While the report has not been confirmed, the analyst believes that the business will be lost after 2019. Longer term, the analyst keeps his Outperform rating and $20 price target on Mattel and believes that its management "can facilitate needed changes in culture, product development, digital content, and partner relationships to drive sales and earnings growth."
HAS Hasbro
$106.65

0.95 (0.90%)

04/25/19
ARGS
04/25/19
DOWNGRADE
ARGS
Hold
Hasbro downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded Hasbro to Hold while also lowering his FY19 and FY20 EPS outlook by 10c to $4.40 and $5.00 respectively. The analyst believes that it will be "difficult" for the company to recover revenue lost from the Toys "R" Us bankruptcy, also pointing to rising costs related to new product launches. At 22.9-times his expected FY19 earnings, Staszak sees Hasbro stock as "fully valued" and above the 18-times multiple for "other leisure products companies."
04/25/19
ARGS
04/25/19
DOWNGRADE
ARGS
Hold
Hasbro downgraded to Hold from Buy at Argus
04/24/19
RHCO
04/24/19
NO CHANGE
Target $100
RHCO
Hold
Hasbro price target raised to $100 from $88 at SunTrust
SunTrust analyst Michael Swartz raised his price target on Hasbro to $100 after its Q1 results marked a "solid start to the year." The analyst cautions however that while the performance "shook off doubts" that the company could return to growth in 2019, Q1 earnings can be "extremely volatile and relatively immaterial" to FY results. Swartz is keeping his Hold rating on Hasbro shares.
04/24/19
DADA
04/24/19
NO CHANGE
Target $120
DADA
Buy
Hasbro price target raised to $120 from $103 at DA Davidson
DA Davidson analyst Linda Bolton Weiser raised her price target on Hasbro to $120 and kept her Buy rating after its Q1 results, with a 6% constant-currency sales growth driving the 14% sales upside surprise. The analyst says her long-term bullish thesis is "playing out" with the annual growth rate of the company's Entertainment, Licensing & Digital business profits coming at 17% over the past 6 years. Weiser adds that there are few signs of a slowdown given the "outlook for future entertainment productions, Power Rangers licensing royalties, and Magic the Gathering Arena", which is already an 8th ranked e-sports game.

TODAY'S FREE FLY STORIES

LVMUY

LVMH

$0.00

(0.00%)

13:52
07/15/19
07/15
13:52
07/15/19
13:52
Hot Stocks
LVMH announces partnership with Stella McCartney »

Stella McCartney and LVMH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SCHW

Charles Schwab

$40.49

0.47 (1.17%)

13:51
07/15/19
07/15
13:51
07/15/19
13:51
Recommendations
Charles Schwab analyst commentary  »

Wells says Schwab deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

AMC

AMC Entertainment

$9.45

(0.00%)

13:45
07/15/19
07/15
13:45
07/15/19
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

13:43
07/15/19
07/15
13:43
07/15/19
13:43
Periodicals
Trump ponders firing Commerce Secretary Wilbur Ross, NBC News says »

According to an earlier…

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$36.65

-0.03 (-0.08%)

13:35
07/15/19
07/15
13:35
07/15/19
13:35
Options
Medicines Company put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTGN

Neon Therapeutics

$4.61

0.3 (6.96%)

13:30
07/15/19
07/15
13:30
07/15/19
13:30
Recommendations
Neon Therapeutics analyst commentary  »

Neon Therapeutics'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

SYMC

Symantec

$21.73

-3.83 (-14.98%)

, AVGO

Broadcom

$289.18

3.79 (1.33%)

13:27
07/15/19
07/15
13:27
07/15/19
13:27
Periodicals
Broadcom was willing to pay up $28.25 per share for Symantec, Reuters reports »

Symantec (SYMC) walked…

SYMC

Symantec

$21.73

-3.83 (-14.98%)

AVGO

Broadcom

$289.18

3.79 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$25.55

1.25 (5.14%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Options
Cara Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
Stephens consumer/poultry & egg analysts hold analyst/industry conference call »

Analysts provide an…

A

Agilent

$69.90

-1.75 (-2.44%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
The Brookings Institution to hold a conference »

8th annual Municipal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

, GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

13:24
07/15/19
07/15
13:24
07/15/19
13:24
Periodicals
Trump administration 'taking aim' at Google, FBN's Gasparino says »

Charles Gasparino of Fox…

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/15/19
07/15
13:17
07/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/15/19
07/15
13:16
07/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$41.12

-0.47 (-1.13%)

13:15
07/15/19
07/15
13:15
07/15/19
13:15
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

OSAGY

Osram

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
Osram announces interest from AMS, sees 'rather low' probability of deal »

Osram Licht said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
BAE Systems reports award of $45M contract from U.S. Army »

The U.S. Army has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

, GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

13:07
07/15/19
07/15
13:07
07/15/19
13:07
On The Fly
Fly Insider: G-III, Target among week's notable insider transactions »

Welcome to "Fly Insider,"…

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

OPK

Opko Health

$2.14

-0.025 (-1.15%)

THO

Thor Industries

$58.96

-0.4 (-0.67%)

GEF

Greif

$33.90

-0.68 (-1.97%)

INSG

Inseego

$5.19

0.03 (0.58%)

FDS

FactSet

$293.90

-2.66 (-0.90%)

TREE

LendingTree

$428.63

-4.28 (-0.99%)

MKC

McCormick

$159.84

1.31 (0.83%)

TGT

Target

$86.80

-0.73 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 12

    Aug

  • 21

    Aug

  • 05

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

YELP

Yelp

$35.68

-0.37 (-1.03%)

13:05
07/15/19
07/15
13:05
07/15/19
13:05
Options
Yelp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$18.07

-0.21 (-1.15%)

13:03
07/15/19
07/15
13:03
07/15/19
13:03
Hot Stocks
Conn's settles with SEC over underwriting policies, bad debt provisions »

Conn's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ET

Energy Transfer LP

$14.82

(0.00%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Energy Transfer LP announce binding supplemental open season for Bakken »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$45.86

-0.17 (-0.37%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Blackstone agrees to acquire Vungle, terms not disclosed »

Blackstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

BIDU

Baidu

$115.31

0.41 (0.36%)

, SNAP

Snap

$15.59

-0.01 (-0.06%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Baidu, Snap renew sales partnership »

Baidu (BIDU) and Snap…

BIDU

Baidu

$115.31

0.41 (0.36%)

SNAP

Snap

$15.59

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 23

    Jul

INTC

Intel

$49.91

(0.00%)

, AMD

AMD

$34.42

1.22 (3.67%)

12:56
07/15/19
07/15
12:56
07/15/19
12:56
Recommendations
Intel, AMD analyst commentary at RBC Capital »

RBC sees AMD continuing…

INTC

Intel

$49.91

(0.00%)

AMD

AMD

$34.42

1.22 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FB

Facebook

$203.64

-1.265 (-0.62%)

12:52
07/15/19
07/15
12:52
07/15/19
12:52
Hot Stocks
Facebook's Marcus says company won't immediately profit from Libra »

In testimony for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

, AMGN

Amgen

$177.08

2.21 (1.26%)

12:51
07/15/19
07/15
12:51
07/15/19
12:51
Recommendations
Cytokinetics, Amgen analyst commentary at Piper Jaffray »

Piper reiterates…

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

AMGN

Amgen

$177.08

2.21 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.